Literature DB >> 9821565

Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder.

E R Peskind1, C F Jensen, M Pascualy, D Tsuang, D Cowley, D C Martin, C W Wilkinson, M A Raskind.   

Abstract

BACKGROUND: Although experimental induction of panic by infusion of 0.5 mol/L sodium lactate in persons with panic disorder was described three decades ago, the mechanism underlying this observation remains unclear. Here we asked if the rapid administration of the large sodium load contained in the 0.5-mol/L sodium lactate infusion might be involved in panic induction.
METHODS: We compared in panic disorder and healthy subjects behavioral, electrolyte, endocrine, and acid-base responses to three double-blind randomly ordered equal volume 20-min infusions: 0.5 mol/L sodium lactate, hypertonic saline (3% sodium chloride), and normal saline placebo.
RESULTS: Sodium lactate (0.5 mol/L) and hypertonic saline produced the same high incidence of panic and equivalent increases in panic symptoms, serum sodium, and plasma vasopressin in the panic disorder subjects. Neither hypertonic infusion increased cortisol or adrenocorticotropin. No normal subject experienced panic in any condition. The 0.5-mol/L sodium lactate infusion induced alkalosis, whereas hypertonic saline and normal saline induced a mild acidosis.
CONCLUSIONS: Hypertonic sodium solution containing either chloride or lactate anion induces panic in panic disorder. The large sodium loads delivered by hypertonic saline and 0.5 mol/L sodium lactate may be involved in the mechanism of panic induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821565     DOI: 10.1016/s0006-3223(98)00053-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

Review 1.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

Review 2.  Lactate in the brain: from metabolic end-product to signalling molecule.

Authors:  Pierre J Magistretti; Igor Allaman
Journal:  Nat Rev Neurosci       Date:  2018-03-08       Impact factor: 34.870

Review 3.  A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans.

Authors:  Christian Grillon; Monique Ernst
Journal:  Neurosci Biobehav Rev       Date:  2020-10-07       Impact factor: 8.989

Review 4.  Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

Authors:  Philip L Johnson; Lauren M Federici; Anantha Shekhar
Journal:  Neurosci Biobehav Rev       Date:  2014-08-15       Impact factor: 8.989

Review 5.  An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Authors:  Philip L Johnson; Anantha Shekhar
Journal:  Physiol Behav       Date:  2012-03-26

6.  Elevated tph2 mRNA expression in a rat model of chronic anxiety.

Authors:  Nina C Donner; Philip L Johnson; Stephanie D Fitz; Karen E Kellen; Anantha Shekhar; Christopher A Lowry
Journal:  Depress Anxiety       Date:  2012-04       Impact factor: 6.505

7.  Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder.

Authors:  Andre I Molosh; Philip L Johnson; Stephanie D Fitz; Joseph A Dimicco; James P Herman; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2010-02-03       Impact factor: 7.853

Review 8.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

9.  Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.

Authors:  Philip L Johnson; Tammy J Sajdyk; Stephanie D Fitz; Mathew W Hale; Christopher A Lowry; Anders Hay-Schmidt; Anantha Shekhar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-21       Impact factor: 5.067

10.  Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.

Authors:  Samir Khan; Hedieh Briggs; James Lawrence Abelson
Journal:  Psychiatry Res       Date:  2008-01-28       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.